Onyda XR: payments to doctors
Payments that named Onyda XR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $586K
- Providers
- 2,092
- Transactions
- 3,560
- Average per transaction
- $165
The per-transaction average — $165 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,092 providers the average total is $280, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Tris Pharma Inc | $585,834 | 100.0% |